News

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...
Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...
As discussions unfold, Kennedy seeks to balance drug accessibility with concerns about the long-term costs of providing GLP-1 ...
on Thursday, March 27, 2025. (AP Photo/Susan Haigh) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] ...
This week has been a brutal reminder of how politics and politicians like to work and be seen. How important it is to be the ...
A new paper by the Institute for Clinical and Economic Review (ICER) looks at the cost-effectiveness versus affordability ...
President Donald Trump signed an executive order on the healthcare sector yesterday, aiming to lower prescription drug prices ...
States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching for ways to get out from under the budgetary squeeze that took them ...